Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
Response to Ng et al.
- Dawn Smiley, MD and
- Guillermo Umpierrez, MD
- From the Endocrinology Section, Emory University, Atlanta, Georgia
- Address correspondence to Guillermo E. Umpierrez, MD, Endocrinology Section, Emory University, 49 Jesse Hill Jr. Dr., Atlanta, Georgia
We reported that hypertension affects nearly 70% of patients with type 2 diabetes at our institution and that 45% of them require three or more antihypertensive agents (1). Despite the multidrug approach, one-third of patients do not achieve the recommended blood pressure goal of <130/80 mmHg. These findings led us to investigate the prevalence of primary hyperaldosteronism (PHA), the most common cause of endocrine hypertension, in diabetic patients with resistant hypertension. We found that 14% of diabetic patients with resistant hypertension had biochemical evidence of PHA. Thus, select patients with diabetes should …
